⌘K

Launch Terminal

Apimeds Pharmaceuticals US, Inc

NYSE:APUSHealthcare · Biotechnology

Mkt Cap$4.71M

Float–

Shares O/S1.54M

Inst Own2.8%

Dilution

PrePre-market-2.62%$2.97

Close$3.05+5.35%

AH Close$3.05-2.62%since AH close

Close$3.05+5.35%AH$3.05-2.62%since

Mkt Cap$4.71M

Float–

O/S1.54M

Inst Own2.8%

Dilution

NYSE:APUSPre$2.97-2.62%Close$3.05+5.35%

MCap$4.71M

Float–

O/S1.54M

Inst Own2.8%

Dilution

Form	Description		Links
8-K	CURRENT REPORT 3	10/13/26Oct 13, 2026
8-K	CURRENT REPORT 2	10/1/26Oct 1, 2026
8-K	CURRENT REPORT 4	9/29/26Sep 29, 2026
8-K	CURRENT REPORT 2	9/23/26Sep 23, 2026
8-K	CURRENT REPORT 4	9/11/26Sep 11, 2026
8-K	CURRENT REPORT 3	8/21/26Aug 21, 2026
10-Q	QUARTERLY REPORT 11	8/14/26Aug 14, 2026
8-K	CURRENT REPORT 2	8/6/26Aug 6, 2026
8-K	CURRENT REPORT 1	7/13/26Jul 13, 2026
10-Q	QUARTERLY REPORT 6	5/26/26May 26, 2026
NT 10-Q	NOTIFICATION OF LATE FILING 2	5/15/26May 15, 2026
13D/A	Beneficial Ownership Report (Active, Amended)	5/7/26May 7, 2026
8-K	CURRENT REPORT 2	5/5/26May 5, 2026
10-K	ANNUAL REPORT	5/4/26May 4, 2026
8-K	CURRENT REPORT	5/4/26May 4, 2026
8-K	3.01,9.01 3	4/22/26Apr 22, 2026
8-K	CURRENT REPORT	4/16/26Apr 16, 2026
425	AMENDMENT NO. 1 TO FORM 8-K	4/9/26Apr 9, 2026
8-K/A	AMENDMENT NO. 1 TO FORM 8-K	4/9/26Apr 9, 2026
NT 10-K	NOTIFICATION OF LATE FILING	3/31/26Mar 31, 2026
13D/A	Beneficial Ownership Report (Active, Amended)	3/30/26Mar 30, 2026
8-K	CURRENT REPORT	3/26/26Mar 26, 2026
8-K	CURRENT REPORT	3/25/26Mar 25, 2026
13D/A	Beneficial Ownership Report (Active, Amended)	3/20/26Mar 20, 2026
8-K	CURRENT REPORT	3/16/26Mar 16, 2026

1-25 of 127 filings

…